Enter assignee name

Forward Citations = 44

Loading Chart...

17 inventors (with patents filed for the assignee):

Steven L Colletti (4 out of 40 patents)

Matthew G Stanton (3 out of 69 patents)

Brian W Budzik (2 out of 12 patents)

4. Hongbiao Liao (1 out of 13 patents)

5. David M Tellers (1 out of 21 patents)

6. Brandon Ason (1 out of 4 patents)

7. Walter R Strapps (1 out of 19 patents)

8. Yu Yuan (1 out of 9 patents)

9. Norihiro Ikemoto (1 out of 2 patents)

10. Craig Parish (1 out of 2 patents)

11. Tao Pei (1 out of 3 patents)

12. Quang Truong (1 out of 2 patents)

13. Lijun Wang (1 out of 3 patents)

14. Man Zhu (1 out of 2 patents)

15. Vadim Y Dudkin (1 out of 16 patents)

5 patents: Sort by Forward Citations

1. 11332745 - RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (SINA) (2022-05-17),

2. 10214742 - Tetragalnac containing conjugates and methods for delivery of oligonucleotides (2019-02-26),

3. 9604908 - Diether based biodegradable cationic lipids for siRNA delivery (2017-03-28),

4. 9446132 - Diether based biodegradable cationic lipids for siRNA delivery (2016-09-20),

5. 9402816 - Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide delivery (2016-08-02),

Sima Therapeutics, Inc. is a biotechnology company focused on developing advanced cell therapies for the treatment of cancer and genetic diseases. With a team of experienced scientists and cutting-edge technology, Sima Therapeutics is dedicated to revolutionizing healthcare through innovative gene editing techniques and personalized medicine solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#336 in Cambridge, MA

#2,815 in Massachusetts

#50,245 in US

Cambridge, MA, United States of America

Sima Therapeutics, Inc.